IRIS
MORI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.315
EU - Europa 7.930
AS - Asia 4.935
SA - Sud America 1.336
Continente sconosciuto - Info sul continente non disponibili 624
AF - Africa 258
OC - Oceania 12
Totale 26.410
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.083
IT - Italia 1.984
RU - Federazione Russa 1.647
SG - Singapore 1.647
CN - Cina 1.280
GB - Regno Unito 1.200
BR - Brasile 1.086
IE - Irlanda 1.014
VN - Vietnam 691
FR - Francia 503
HK - Hong Kong 495
SE - Svezia 388
DE - Germania 349
UA - Ucraina 336
KR - Corea 184
FI - Finlandia 176
IN - India 139
BD - Bangladesh 122
AR - Argentina 115
CA - Canada 112
ZA - Sudafrica 105
TR - Turchia 64
ES - Italia 55
NL - Olanda 49
MX - Messico 48
CZ - Repubblica Ceca 40
IQ - Iraq 40
PK - Pakistan 39
PL - Polonia 39
ID - Indonesia 38
EC - Ecuador 36
JP - Giappone 35
AT - Austria 31
CO - Colombia 28
CI - Costa d'Avorio 26
KE - Kenya 26
SA - Arabia Saudita 24
CL - Cile 22
NG - Nigeria 20
BE - Belgio 19
MA - Marocco 18
EG - Egitto 17
AE - Emirati Arabi Uniti 16
VE - Venezuela 16
BG - Bulgaria 14
TN - Tunisia 14
DZ - Algeria 12
IR - Iran 12
JM - Giamaica 12
JO - Giordania 12
MY - Malesia 12
PT - Portogallo 11
PY - Paraguay 11
HN - Honduras 10
UZ - Uzbekistan 10
AU - Australia 9
AZ - Azerbaigian 9
CR - Costa Rica 9
GR - Grecia 9
PE - Perù 9
LT - Lituania 8
NP - Nepal 8
SC - Seychelles 8
UY - Uruguay 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
EU - Europa 7
IL - Israele 7
KZ - Kazakistan 6
SV - El Salvador 6
AL - Albania 5
BY - Bielorussia 5
EE - Estonia 5
GT - Guatemala 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
CY - Cipro 4
HU - Ungheria 4
LB - Libano 4
PA - Panama 4
RO - Romania 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BO - Bolivia 3
DK - Danimarca 3
GE - Georgia 3
KG - Kirghizistan 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
PH - Filippine 3
PS - Palestinian Territory 3
QA - Qatar 3
SI - Slovenia 3
SN - Senegal 3
AM - Armenia 2
BM - Bermuda 2
ET - Etiopia 2
GY - Guiana 2
Totale 25.755
Salva come PNG Salva come JPEG
Città #
Dallas 1.628
Southend 1.012
Ashburn 1.011
Dublin 1.006
Fairfield 941
Singapore 823
Milan 607
San Jose 536
Woodbridge 477
Hong Kong 470
Moscow 456
Seattle 419
Beijing 400
Council Bluffs 366
Chandler 354
Wilmington 352
Houston 345
Santa Clara 340
Cambridge 328
Siena 310
Rome 237
Hefei 224
Jacksonville 224
Ann Arbor 207
Ho Chi Minh City 207
Menlo Park 201
Princeton 201
Seoul 182
Los Angeles 172
Hanoi 155
New York 152
Lauterbourg 149
The Dalles 145
San Mateo 97
Munich 91
São Paulo 88
Helsinki 87
Johannesburg 76
Buffalo 75
Boardman 73
San Diego 70
Nanjing 65
Columbus 62
Dong Ket 62
Figino 60
Redwood City 60
Florence 53
Chicago 46
Phoenix 44
Bengaluru 42
Redondo Beach 42
Shanghai 42
Lappeenranta 41
London 41
Fremont 39
Turin 38
Rio de Janeiro 36
Nuremberg 30
Tokyo 29
Brno 28
San Francisco 28
Haiphong 27
Abidjan 26
Frankfurt am Main 26
Izmir 26
Atlanta 24
Montreal 24
Orem 24
Nanchang 23
Washington 23
Brooklyn 22
Düsseldorf 22
North Bergen 22
Baghdad 21
Chennai 21
Da Nang 21
Salamanca 21
Warsaw 21
Boston 20
Shenyang 20
Belo Horizonte 19
Brasília 19
Brussels 19
Denver 19
Miami 19
Naples 19
Norwalk 19
Hải Dương 18
Jinan 18
Abuja 17
Toronto 17
Curitiba 16
Mexico City 16
Philadelphia 16
Salt Lake City 16
Bologna 15
Dearborn 15
Guangzhou 15
Buenos Aires 14
Turku 14
Totale 16.956
Salva come PNG Salva come JPEG
Nome #
Biological Evaluation and Computational Modelling Studies on N-acyl Hydrazone and 2,5-Disubstituted 1,3,4-Oxadiazole Derivatives as Non-toxic Antimicrobial Agents 516
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors 425
Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02 357
Structure, function, involvement in diseases and targeting of 14-3-3 proteins: An Update 322
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity 311
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains 308
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors 300
Molecular insights to the bioactive form of BV02, a reference inhibitor of 14-3-3σ protein-protein interactions 298
Differentially activated Src kinase in chemo-naive human primary osteosarcoma cells and effects of a Src kinase inhibitor 284
Tautomers of a Fluorescent G Surrogate and Their Distinct Photophysics Provide Additional Information Channels 283
Potent and selective carboxylic acid inhibitors of tumor-associated carbonic anhydrases IX and XII 282
In Memory of Maurizio Botta: His Contribution to the Development of Computer-Aided Drug Design 277
Identification of Phosphate-Containing Compounds as New Inhibitors of 14-3-3/c-Abl Protein-Protein Interaction 274
Discovery of in vitro antitubercular agents through in silico ligand-based approaches 272
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein 269
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3s case 268
Discovery of 14-3-3 Protein-Protein Interaction Inhibitors that Sensitize Multidrug-Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693 264
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 264
Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein 250
A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro 249
Hit Recycling: Discovery of a Potent Carbonic Anhydrase Inhibitor by in Silico Target Fishing 248
Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated caxii 240
Molecular Dynamics and DFT Study on HIV-1 Nucleocapsid Protein-7 in Complex with Viral Genome 235
Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors 234
Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor 233
Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein 232
Small molecules modulation of 14-3-3 protein–protein interactions 231
Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1 224
Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B 224
A Class of Potent Inhibitors of the HIV-1 Nucleocapsid Protein Based on Aminopyrrolic Scaffolds 215
Mycobacterial carbonic anhydrase inhibition with phenolic acids and esters: kinetic and computational investigations 212
Structure Prediction and Validation of the ERK8 Kinase Domain 207
Multitarget hedgehog pathway inhibitors and uses thereof 200
Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90 chaperone 198
Hedgehog Pathway Inhibition by Novel Small Molecules Impairs Melanoma Cell Migration and Invasion under Hypoxia 195
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors 192
Free energy profile and kinetics studies of paclitaxel internalization from the outer to the inner wall of microtubules 191
Probing the Pore Drug Binding Site ofMicrotubules with Fluorescent Taxanes:Evidence of Two Binding Poses 191
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines 187
1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma 187
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge 186
Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid protein 185
Predicting the binding mode of known NCp7 inhibitors to facilitate the design of novel modulators 184
Predicting the Binding Mode of Known NCp7 Inhibitors To Facilitate the Design of Novel Modulators 183
A smo/gli multitarget hedgehog pathway inhibitor impairs tumor growth 179
Targeting Protein-Protein and Protein-Nucleic Acid Interactions for Anti-HIV Therapy 176
Nigritanine as a new potential antimicrobial alkaloid for the treatment of staphylococcus aureus-induced infections 176
A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome 175
Discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (PtpB) inhibitors from natural products 173
A Molecular Tool Targeting the Base-Flipping Activity of Human UHRF1 173
Nucleocapsid protein: A desirable target for future therapies against HIV-1 172
Natural products inspired modulators of cancer stem cells-specific signaling pathways notch and hedgehog 170
Experimental and Computational Druggability Exploration of the 14-3-3ζ/SOS1pS1161PPI Interface 170
Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity 167
A unique high-diversity natural product collection as a reservoir of new therapeutic leads 164
Targeting GLI factors to inhibit the Hedgehog pathway 161
Alvaxanthone, a thymidylate synthase inhibitor with nematocidal and tumoricidal activities 161
14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban 158
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: synthesis and biological evaluation for chronic myeloid leukemia treatment 155
A chalcone derivative binds a putative allosteric site of YopH: Inhibition of a virulence factor of Yersinia 154
Oregonin from Alnus incana bark affects DNA methyltransferases expression and mitochondrial DNA copies in mouse embryonic fibroblasts 153
Synthesis of flexible purine analog inhibitors of NCp7 149
Current trends in Hedgehog signaling pathway inhibition by small molecules 147
Chalcones and Chalcone-mimetic Derivatives as Notch Inhibitors in a Model of T-cell Acute Lymphoblastic Leukemia 147
A deadly spillover: SARS-CoV-2 outbreak 147
Thienoguanosine, a unique non-perturbing reporter for investigating rotational dynamics of DNA duplexes and their complexes with proteins 146
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 146
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 146
Conformational insights into the C-terminal mutations of human rhodopsin in retinitis pigmentosa 146
Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells 145
Histone demethylating agents as potential S-adenosyl-l-methionine-competitors 145
Statins interfere with the attachment of S. cerevisiae mtDNA to the inner mitochondrial membrane 144
INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARN T 144
Natural flavonoid derivatives have pan-Coronavirus antiviral activity 143
Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold 143
P300/CBP-associated factor regulates transcription and function of isocitrate dehydrogenase 2 during muscle differentiation 142
Excited-State Dynamics of Thienoguanosine, an Isomorphic Highly Fluorescent Analogue of Guanosine 141
Yeast as a tool to select inhibitors of the cullin deneddylating enzyme Csn5 140
Synthesis of distal and proximal fleximer base analogues and evaluation in the nucleocapsid protein of HIV-1 140
Selective targeting of cancer-related G-Quadruplex structures by the natural compound dicentrine 139
What makes thienoguanosine an outstanding fluorescent DNA probe? 138
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells 138
Targeting the nucleocapsid protein of HIV-1 (NCp7) with nucleobase flexibility 137
Hedgehog signaling pathway inhibitors: an updated patent review (2015–present) 135
Active Components from Cassia abbreviata Prevent HIV-1 Entry by Distinct Mechanisms of Action 135
Synthetic thiosemicarbazones as a new class of Mycobacterium tuberculosis protein tyrosine phosphatase A inhibitors 133
Natural products as an important source in drug discovery 133
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 132
Imidazo[1,2-a]pyridine derivatives as aldehyde dehydrogenase inhibitors: novel chemotypes to target glioblastoma stem cells 132
Novel insights on human carbonic anhydrase inhibitors based on coumalic acid: design, synthesis, molecular modeling investigation, and biological studies 130
Ent-Beyerane Diterpenes as a Key Platform for the Development of ArnT-Mediated Colistin Resistance Inhibitors 130
Antimalarial drugs: what's new in the patents? 129
Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein 129
Molecular Dynamics Simulations and Structural Analysis of Giardia Duodenalis 14-3-3 Protein-Protein Interactions 128
Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia 126
One hundred faces of cyclopamine 125
Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity 125
Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold 124
Dual SMO/BRAF inhibition by flavonolignans from Silybum marianum† 124
DNA and RNA polymerases 123
Totale 19.270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.922
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.060 0 0 0 30 51 89 75 53 119 154 176 313
2022/20231.669 144 172 249 237 95 351 33 119 142 37 44 46
2023/20241.725 48 32 130 139 39 395 518 60 13 38 51 262
2024/20253.726 118 262 264 280 279 185 148 162 336 272 382 1.038
2025/20269.983 671 1.304 1.588 1.258 1.480 271 860 270 350 496 446 989
2026/20271.987 437 349 717 484 0 0 0 0 0 0 0 0
Totale 26.410